PMV Pharmaceuticals
PMVP
PMVP
111 hedge funds and large institutions have $246M invested in PMV Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 44 increasing their positions, 35 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
6.94% less ownership
Funds ownership: 119.42% → 112.49% (-6.9%)
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
48% less capital invested
Capital invested by funds: $470M → $246M (-$224M)
Holders
111
Holding in Top 10
4
Calls
$161K
Puts
$99K
Top Buyers
| 1 | +$6.56M | |
| 2 | +$2.76M | |
| 3 | +$2.06M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.93M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.34M |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$6.48M | |
| 3 | -$4.12M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$3.97M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.77M |